Emervel dermal fillers offer affordable beauty without the need for surgery, revitalising skin by smoothing lines and folds, and restoring volume in the cheeks and chin. By utilising scientifically advanced technology, the Emervel product range provides up to five different dermal filler products for use at different layers of the skin.
Owned by one of the fastest growing pharmaceutical companies within the UK, Galderma, Emervel replaces the skin’s naturally decreasing hyaluronic acid, restoring face volume and correcting wrinkles.
Founded over 30 years ago, Galderma is a world-leading corrective and aesthetic dermatology company focused on developing innovative skin treatments for medical and aesthetic use. A joint venture between Nestle and L’Oreal, Galderma now employs over 3,000 members of staff worldwide.
As a new-to-market product, our digital strategy was to source an appropriate content management system for the website design and build project, which could be edited and managed by the client and accessed across the world.
Owned by global pharmaceutical company, Galderma, our strategy needed to appease and meet the needs of numerous stakeholders from various markets. We therefore worked closely with stakeholders from the various European territories to create a ‘wish list’ of website functionalities, from social media integration through to stockist details.
Essentially, the Emervel website would need to act as a cost effective route to market for Galderma’s newest dermatology product.
Taking into consideration various stakeholder requirements, and adhering to the strict brand guidelines, we selected a suitable content management system to consolidate all requirements from European Galderma stakeholders.
Built on flexible and expandable CMS, Umbraco, the Emervel website can be managed and edited with ease, empowering the client and ensuring changes and updates to the website can be made as and when necessary.
The website incorporates innovative before and after technology in order to clearly demonstrate the effectiveness of the new-to-market product, engaging users and encouraging potential customers to try the new to market dermal fillers.
Following launch, we have received positive feedback from both the client and website users. The before and after technology has been particularly well received and has contributed to impressive sales of the dermal fillers.
We have continued to work with Galderma, rolling out a variety of other products online, including the popular acne cream, Epiduo.